Long-Term Outcomes after Conversion to a Belatacept-Based Immunosuppression in Kidney Transplant Recipients

CONCLUSIONS: This study shows that conversion to belatacept post-transplant was associated with lower risk of graft failure and acceptable safety outcomes compared with patients maintained on CNI.PMID:38265815 | DOI:10.2215/CJN.0000000000000411

Source: Clinical Journal of the American Society of Nephrology : CJASN - January 24, 2024 Category: Urology & Nephrology Authors: Gillian Divard Olivier Aubert Charlotte Debiais-Deschamp Marc Raynaud Valentin Goutaudier Marta Sablik Caroline Sayeg Christophe Legendre Julie Obert Dany Anglicheau Carmen Lefaucheur Alexandre Loupy Source Type: research